Very early researchStudy completedNCT02269540
What this trial is testing
A New Treatment Approach for Major Depressive Disorder Based Upon Targeting Monoamine Oxidase A (MAO-A)
Who this might be right for
Major Depressive Disorder
Centre for Addiction and Mental Health 10